학술논문

α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease
Document Type
Article
Source
In: Biology of Blood and Marrow Transplantation. (Biology of Blood and Marrow Transplantation, March 2004, 10(3):204-212)
Subject
Language
English
ISSN
10838791